Paeds · pain-palliative-and-end-of-life-care
Symptom control in serious paediatric illness
Also known as Paediatric palliative symptom management · Management of distressing symptoms in life-limiting illness · Pain and symptom control at the end of life in children · Anticipatory prescribing in paediatric palliative care · Palliative sedation in children · Death rattle and terminal agitation management · Subcutaneous drug administration in the dying child
Fellowship-level approach to recognising and treating the four highest-burden distressing symptoms in a child with a serious, life-limiting or life-threatening illness — pain, breathlessness, nausea and vomiting, and agitation or delirium — together with the related end-of-life phenomena of noisy respiratory secretions (death rattle) and terminal restlessness. Covers the WHO two-step analgesic ladder with weight-based paediatric morphine dosing, safe opioid rotation, anticholinergic choice for secretions, antiemetic matching to the emetic pathway, low-dose haloperidol and midazolam for agitation, titration of palliative sedation for refractory symptoms, the subcutaneous route and syringe driver for the dying child at home, anticipatory (just-in-case) prescribing, and the family-centred goals-of-care conversation that frames every drug decision across ANZ, UK and North American paediatric palliative guidance.
On this page
Related topics
- Palliative care in cancer
- Palliative care in neurodisability and genetic disease
- Withholding and withdrawing life-sustaining treatment
- Procedural pain: topical anaesthesia, preparation, distraction and non-pharmacological support
- Shared decision-making and assent in children
- Family-centred and child-rights-based care
Study tools
Your progress
Saved on this device.
Practise this topic
Target exams
Red flags
- Treating a reversible cause as terminal distress — constipation, urinary retention, hypoglycaemia, hypoxia, sepsis, intracranial bleed and medication adverse effect can all masquerade as agitation or pain at the end of life and must be excluded before attributing the symptom to dying
- Escalating an opioid for agitation or delirium that is actually opioid-induced neurotoxicity — myoclonus, allodynia, confusion and twitching are a signal to rotate opioids or reduce the dose, not to push the same drug higher
- Prescribing codeine or tramadol in a child under 12 years, or in any child under 18 after adenotonsillectomy — CYP2D6 ultrarapid metabolism can produce lethal respiratory depression; use morphine
- Failing to prescribe anticipatory (just-in-case) medicines for a child expected to die at home, so that the first breathlessness, pain, seizure or agitation episode finds the family with no drug and no plan
- Using repeated blind suction for death rattle on an unconscious child — it distresses the child, rarely helps, and the family is usually the distressed party; use an anticholinergic and position
- Sedating a child because staff or the family are distressed rather than because the symptom is refractory — palliative sedation must be proportionate to a refractory symptom, not a response to the room's discomfort
- Rotating opioids at full equianalgesic dose — always reduce by 25 to 50 per cent for incomplete cross-tolerance, and seek specialist input for methadone whose ratio rises steeply at high doses
Life stages
Care settings
Clinical exam formats
Board mappings
- General Paediatrics — recognise and assess distressing symptoms in a seriously ill child
- Apply the WHO analgesic ladder with weight-based paediatric dosing
- Recognise the deteriorating or dying child and the need for palliative input
- Paediatric palliative care — lead multidisciplinary symptom control in life-limiting illness
- Perform a safe opioid rotation and titrate palliative sedation for refractory symptoms
- Coordinate home-based palliative symptom care with anticipatory prescribing
- Written Examination — pharmacology and ethics of symptom control in serious paediatric illness
- Clinical Applications — symptom assessment, opioid dosing, palliative sedation, end-of-life ethics
- Long case — the child with a life-limiting illness and escalating symptoms
- Communication station — goals-of-care and anticipatory prescribing conversation
- Short case — bedside assessment of pain, breathlessness and agitation
- Level 2 — manages common symptoms at the end of life in partnership with palliative care
- Patient safety — anticipatory prescribing and opioid safety in the dying child
- Safeguarding and communication — family-centred end-of-life care and honest conversations
- Applied Knowledge in Practice — palliative symptom pharmacology and the WHO ladder
- Foundations of Practice — ethics of palliative sedation and the doctrine of double effect
- Communication scenario — breaking bad news, goals of care and anticipatory prescribing
- History and management — the child with a life-limiting illness and distressing symptoms
- General Pediatrics Content Outline — palliative and end-of-life care
- General Pediatrics EPA — manage distressing symptoms in a seriously ill child
- Patient Care — provide palliative symptom management aligned with goals of care
- Systems-Based Practice — coordinate home and hospice palliative services
- Professionalism — honest, family-centred end-of-life communication
- Pediatrics — palliative care and symptom management in serious illness
- Medical Expert and Communicator — goals-of-care and anticipatory prescribing
Overview & Definition
Picture the nine-year-old with relapsed neuroblastoma who is now breathless, in pain and frightened, or the toddler with spinal muscular atrophy type 1 who has begun to struggle with secretions. Neither child is curable, but both can be comfortable, and the work of making them comfortable is what this page is about. Symptom control here means the active, planned, evidence-based relief of the physical and emotional distress caused by a serious illness, whether that illness is being treated for cure, for prolongation of life, or for comfort alone. [1] [3]
The defining shift in paediatric palliative symptom control is a change of goal, not of effort. In curative care you investigate a symptom to find and treat the cause, and you tolerate the symptom meanwhile. In palliative symptom control you treat the symptom now, you look for reversible causes in parallel, and you weigh every test and treatment against the burden it adds. A chest X-ray that requires a painful transfer may still be justified if a pleural effusion can be drained and the breathlessness cured, but the same transfer may be the wrong choice in a child who is imminently dying and for whom an opioid, positioning and a parent's lap will do. The decision belongs to the family and the team together, anchored in what matters to this child. [1] [8]
Cicely Saunders named this total pain: the suffering a child experiences is never only nociceptive input. It is the pain itself, plus the fear of what the pain means, plus the anxiety of separation from home and family, plus the spiritual distress of a child old enough to feel that dying is unfair, plus the social pain of a family falling apart under the strain. Treat only the nociceptive component and you will fail; the child will still cry. The discipline of palliative symptom control is to address each layer — pharmacologically, psychologically, in play and music and presence, and in honest conversation with the family — while the pharmacology does its share of the work. [3] [12]
References12ShowHide
- [1]van Teunenbroek KC, Mulder RL, Ahout IML, et al A Dutch paediatric palliative care guideline: a systematic review and evidence-based recommendations for symptom treatment. BMC Palliat Care, 2024.PMID 38481215
- [2]Zernikow B, Michel E, Craig F, Anderson BJ Pediatric palliative care: use of opioids for the management of pain. Paediatr Drugs, 2009.PMID 19301934
- [3]Friedrichsdorf SJ, Bruera E Delivering Pediatric Palliative Care: From Denial, Palliphobia, Pallilalia to Palliactive. Children (Basel), 2018.PMID 30200370
- [4]García-López I, Chocarro-González L, Martín-Romero I, et al Pediatric Palliative Care at Home: A Prospective Study on Subcutaneous Drug Administration. J Pain Symptom Manage, 2023.PMID 37244525
- [5]Chen Y, Jiang J, Peng W, Zhang C Palliative sedation for children at end of life: a retrospective cohort study. BMC Palliat Care, 2022.PMID 35473555
- [6]Harris N, Baba M, Mellor C, et al Seizure management in children requiring palliative care: a review of current practice. BMJ Support Palliat Care, 2020.PMID 28687558
- [7]Fife A, Postier A, Flood A, Friedrichsdorf SJ Methadone conversion in infants and children: Retrospective cohort study of 199 pediatric inpatients. J Opioid Manag, 2016.PMID 27194197
- [8]Henson LA, Maddocks M, Evans C, et al Palliative Care and the Management of Common Distressing Symptoms in Advanced Cancer: Pain, Breathlessness, Nausea and Vomiting, and Fatigue. J Clin Oncol, 2020.PMID 32023162
- [9]Hui D, Bohlke K, Bao T, et al Management of Dyspnea in Advanced Cancer: ASCO Guideline. J Clin Oncol, 2021.PMID 33617290
- [10]Wee B, Hillier R Interventions for noisy breathing in patients near to death. Cochrane Database Syst Rev, 2008.PMID 18254072
- [11]Hugel H, Ellershaw J, Gambles M Respiratory tract secretions in the dying patient: a comparison between glycopyrronium and hyoscine hydrobromide. J Palliat Med, 2006.PMID 16629557
- [12]Lindqvist O, Lundquist G, Dickman A, et al Four essential drugs needed for quality care of the dying: a Delphi-study based international expert consensus opinion. J Palliat Med, 2013.PMID 23234300